Table 4.
Proteins, peptides and nucleic acids delivered by polymeric nanocarriers: conditions used for the fractionation. All drugs were quantified by online UV/Vis spectrometry
| Drug | Nanocarrier | Eluent | Ref | |
|---|---|---|---|---|
| Antibodies | Human IgG1-R, IgG1-T, murine IgG2a-A20 Id | Keyhole limpet hemocyanin conjugates | 1 × PBS (pH 7.2) + 0.02% NaN3 | [195] |
| Other proteins/peptides | Esterase (porcine liver), myoglobin (equine skeletal muscle) | PEG-DEAEMA-DMIBMA polymersomes | 1 × PBS + 0.02% NaN3 | [144] |
| Peptide PCS5 | Chitosan/dextran sulfate nanoparticles | SDS 0.1% | [38] | |
| Several proteins | Polyphosphazene (PCPP and PCEP) complexes | 1 × PBS (pH 7.4) | [105] | |
| Lysozyme | Spermine-crosslinked polyphosphazene (PCPP and PCPP-PEG) nanoparticles | 1 × PBS (pH 7.4) | [196] | |
| Nerve growth factor | PMOXA − PDMS − PMOXA polymersomes | 10 mM PB (pH 7.4) | [143] | |
| Nucleic acids and nucleosides | Fludarabine-5′-triphosphate, clofarabine-5′-triphosphate | Maltose-modified poly(propyleneimine) dendrimers | 10 mM HEPES (pH 5.8 or 7.4) | [173] |
| pGreen Lantern-1 plasmid | DOTAP/DOPE liposomes | 89 mM Tris-borate (pH 8.59) | [197] | |
| Linear salmon sperm DNA, pEGFP-N1 plasmid | Hybrid micelles (PS-b-PQ2VP/oleic acid-stabilized iron oxide nanoparticles) | 0.02% NaN3 | [198] |
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOTAP 1,2-dioleoyl-3-trimethylammonium propane, PCEP poly[di(carboxylatoethylphenoxy)phosphazene], PCPP poly[di(carboxylatophenoxy)phosphazene, PCPP-PEG poly[di(carboxylatophenoxy)phosphazene-block-polyethylene glycol, PEG-DEAEMA-DMIBMA polyethylene glycol-block-diethylaminoethyl-methacrylate-block-4-(3,4-dimethylmaleicimido)butyl methacrylate, PS-b-PQ2VP polystyrene-blcok-poly(quaternized 2-vinylpyridine)